Pseudomonas aeruginosa virulence factor pathways (PAVP)

Pseudomonas aeruginosa virulence factor pathways represent a complex network of regulatory systems and effector molecules that enable the pathogen to colonize hosts, evade immune responses, and cause systemic damage [Venturi, 2006]. Central to these pathways is Quorum Sensing (QS), a density-dependent signaling mechanism involving the Las, Rhl, and PQS systems that regulates the expression of numerous toxins and enzymes [Lee & Zhang, 2015]. Another critical component is the Type III Secretion System (T3SS), a needle-like apparatus used to inject cytotoxic effectors directly into host cells, facilitating immune evasion and tissue penetration [Hauser, 2009]. Additionally, the production of siderophores for iron acquisition and the formation of robust biofilms are essential for bacterial survival in nutrient-limited and hostile environments [Costerton et al., 1999]. Therapeutic strategies targeting these pathways, known as anti-virulence therapies, aim to attenuate the pathogen's harmful capabilities rather than directly killing the bacteria, which may minimize the development of antimicrobial resistance [Dickey et al., 2017]. Experimental agents include QS inhibitors, T3SS blockers, and monoclonal antibodies designed to neutralize specific toxins or surface proteins [DiGiandomenico et al., 2014].

Other names

Pseudomonas aeruginosa virulence factorsAnti-virulence targetsQuorum sensing pathwaysType III secretion system (T3SS)Biofilm formation pathways

Inhibition of Quorum Sensing (QS) signaling, blockade of Type III Secretion System (T3SS) needle assembly or effector translocation, disruption of biofilm matrix assembly, and sequestration of essential nutrients like iron [Dickey et al., 2017; Hauser, 2009].